Regulator clears clinical trials of Covaxin on children aged 2 to 18 years

Will be conducted on 525 healthy volunteers

Regulator clears clinical trials of Covaxin on children aged 2 to 18 years

In the trial, the vaccine will be given by intramuscular route in two doses at day 0 and day 28. PTI/File

Tribune Web Desk

Chandigarh, May 13

National regulator Drugs Controller General of India (DCGI) has accepted the recommendation of the Subject Expert Committee (SEC) and accorded permission to conduct the phase-II/III clinical trials of Covaxin in the age group 2 to 18 years.

Also read: Covaxin recommended for trial on 2-18 age group

Covaxin manufacturer Bharat Biotech had proposed to carry out the trial, which will be conducted on  525 healthy volunteers. 

In the trial, the vaccine will be given by intramuscular route in two doses at day 0 and day 28.

As rapid regulatory response, the proposal was deliberated by the SEC on May 11.

Top Stories

Delhi Police 'interrogate Twitter India MD' over ‘toolkit row’

Delhi Police 'interrogate Twitter India MD' over ‘toolkit row’

Twitter has lost its status as an intermediary platform in I...

Delhi Police receive complaint against Swara Bhaskar, Twitter India MD in Ghaziabad assault case

Delhi Police receive complaint against Swara Bhaskar, Twitter India MD in Ghaziabad assault case

In a video uploaded on social media, elderly Muslim man had ...

Active Covid cases in India lowest in 71 days

Active Covid cases in India lowest in 71 days

Recovery rate improves to 95.93 per cent

Himachal's Baddi among 9 places for Sputnik V pilot launch

Himachal's Baddi among 9 places for Sputnik V pilot launch

The pilot, to test cold storage at minus 18 degrees, and oth...

Why bail pleas pending, Supreme Court raps Punjab and Haryana High Court

Why bail pleas pending, Supreme Court raps Punjab and Haryana High Court

Says 50% judges should sit on alternate days to hear persons...

Cities

View All